Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Cucherat

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
La Revue Du Praticien|June 13, 2008
[Therapeutic evaluation and the level of proof]Michel Cucherat
European Heart Journal|November 6, 2007
Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trialsMichel Cucherat
Headache|November 26, 2008
Letter to the editor concerning: Pascual J, Mateos V, Roig C, Sanchez-Del-Rio M, Jimenez D. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. Headache. 2007;47(8):1152-1168Michel Cucherat, Michel Dib
Fundamental & Clinical Pharmacology|August 15, 2009
Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysisMichel Lièvre, Michel Cucherat
European Journal of Heart Failure|February 1, 2020
To clip, or not to clip heart failure patients, that is the questionNathan Mewton, Michel Cucherat
Therapie|December 6, 2018
The limitations of observation studies for decision making regarding drugs efficacy and safetyFrançois Gueyffier, Michel Cucherat
Therapie|June 5, 2017
[False positive results or what's the probability that a significant P-value indicates a true effect?]Michel Cucherat, Silvy Laporte
Presse Medicale (Paris, France : 1983)|February 10, 2007
[Noninferiority trials: several simple principles]Eric Vicaut, Michel Cucherat
La Revue Du Praticien|June 21, 2003
[Causality and statistical association (2) Mechanical determinism and stochastic model]François Gueyffier, Michel Cucherat
Journal of Hypertension|September 16, 2015
Is legacy a myth or a reality? We should know, and we do notFrançois Gueyffier, Michel Cucherat
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
La Revue Du Praticien|June 13, 2008
[Therapeutic evaluation and the level of proof]Michel Cucherat
European Heart Journal|November 6, 2007
Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trialsMichel Cucherat
Headache|November 26, 2008
Letter to the editor concerning: Pascual J, Mateos V, Roig C, Sanchez-Del-Rio M, Jimenez D. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. Headache. 2007;47(8):1152-1168Michel Cucherat, Michel Dib
Fundamental & Clinical Pharmacology|August 15, 2009
Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysisMichel Lièvre, Michel Cucherat
European Journal of Heart Failure|February 1, 2020
To clip, or not to clip heart failure patients, that is the questionNathan Mewton, Michel Cucherat
Therapie|December 6, 2018
The limitations of observation studies for decision making regarding drugs efficacy and safetyFrançois Gueyffier, Michel Cucherat
Therapie|June 5, 2017
[False positive results or what's the probability that a significant P-value indicates a true effect?]Michel Cucherat, Silvy Laporte
Presse Medicale (Paris, France : 1983)|February 10, 2007
[Noninferiority trials: several simple principles]Eric Vicaut, Michel Cucherat
La Revue Du Praticien|June 21, 2003
[Causality and statistical association (2) Mechanical determinism and stochastic model]François Gueyffier, Michel Cucherat
Journal of Hypertension|September 16, 2015
Is legacy a myth or a reality? We should know, and we do notFrançois Gueyffier, Michel Cucherat
Pageof 13